Table 1

 Percentage of eyes with transient adverse events reported during the first week after treatment

Adverse eventLatanoprost90° SLT180° SLT360° SLT
Discomfort/pain0%6%20%39%
Uveitis0%31%41%50%
IOP spike0%11%16%27%